Ozempic Lawsuit Updates October 2023 : A study published in the Journal of the American Medical Association (JAMA) provides evidence linking the use of popular weight loss medications, including Ozempic, to an increased risk of serious gastrointestinal issues, including pancreatitis, bowel obstruction, gastroparesis, and biliary disease (which affects the gallbladder)
Combined with the slowed transit effect of the medication itself, this creates a powerful recipe for constipation during the initial treatment phase
Other molecules, namely ipraglifozin, luseoglifozin, and tofoglifozin, are approved only in Japan, while molecules such as ertuglifozin and sotaglifozin are in clinical development
Carnitine appears to block both triiodothyronine (T3) and thyroxine (T4) entry into the cell
Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4
AffiELISA Rat Glutathione S-transferase alpha-4 ELISA [Gsta4]